FW acts on the sale of Biomed Central Group

October 6, 2008

FOX WILLIAMS ACTS ON THE SALE OF BIOMED CENTRAL GROUP
TO SPRINGER SCIENCE + BUSINESS MEDIA

Fox Williams acted on the sale of the entire issued share capital of BioMed Central Group (BMG) to Springer Science + Business Media. 

BMG was launched in May 2000 and pioneered the open access publishing model, providing free access to peer-reviewed research in biological and medical sciences. BMG is the largest open access provider in the world with over 180 peer-reviewed journals. 

BMG's flagship journals include Journal of Biology, BMC Biology, BMC Medicine, Malaria Journal, BMC Bioinformatics and Gerome Biology. All peer-reviewed research articles published by BMG are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. 

Springer Science + Business Media is the world’s second-largest publisher of journals in the science, technology and medicine (STM) sector. 

Matthew Cockerill, Publisher of BioMed Central said: "We are very excited about this new phase of BioMed Central’s growth and development. Springer has been notable among the major STM publishers for its willingness to experiment with open access publishing. BioMed Central has demonstrated that the open access business model can work, and we look forward to continued rapid growth as part of Springer".

Doug Preece (partner) led the team from Fox Williams assisted by James Channo (senior associate) advising BMC. Springer were represented by Howard Kennedy. 


Related pages:

Corporate more

icons Addthis Print Contact Register

Contact

tel: +44 (0) 20 7628 2000
10 Finsbury Square, London, EC2A 1AF
View map

Accreditations

  • Top Ranked Chambers UK 2014 - Leading Firm
  • Ranked in Chambers Europe 2013 - Leading Individual
  • Ranked in Chambers Global 2014 - Leading Firm
  • Legal 500 - Leading Firm
  • The Lawyer UK 200 - Listed Firm
  • The Law Society Excellence Awards 2012 - Shortlisted
  • Investors in People - Bronze